Abstract
Population-based linkage analysis is a new method for analysing genomewide single nucleotide polymorphism (SNP) genotype data in case–control samples, which does not assume a common disease, common variant model. The genome is scanned for extended segments that show increased identity-by-descent sharing within case–case pairs, relative to case–control or control–control pairs. The method is robust to allelic heterogeneity and is suited to mapping genes which contain multiple, rare susceptibility variants of relatively high penetrance. We analysed genomewide SNP datasets for two schizophrenia case–control cohorts, collected in Aberdeen (461 cases, 459 controls) and Munich (429 cases, 428 controls). Population-based linkage testing must be performed within homogeneous samples and it was therefore necessary to analyse the cohorts separately. Each cohort was first subjected to several procedures to improve genetic homogeneity, including identity-by-state outlier detection and multidimensional scaling analysis. When testing only cases who reported a positive family history of major psychiatric disease, consistent with a model of strongly penetrant susceptibility alleles, we saw a distinct peak on chromosome 19q in both cohorts that appeared in meta-analysis (P=0.000016) to surpass the traditional level for genomewide significance for complex trait linkage. The linkage signal was also present in a third case–control sample for familial bipolar disorder, such that meta-analysing all three datasets together yielded a linkage P=0.0000026. A model of rare but highly penetrant disease alleles may be more applicable to some instances of major psychiatric diseases than the common disease common variant model, and we therefore suggest that other genome scan datasets are analysed with this new, complementary method.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berrettini W . Bipolar disorder and schizophrenia: not so distant relatives? World Psychiatry 2003; 2: 68–72.
McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356–369.
McClellan JM, Susser E, King MC . Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 2007; 190: 194–199.
Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T et al. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445–449.
Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477–488.
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539–543.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
Van den Oord EJCG, Rujescu D, Robles JR, Giegling I, Birrell C, Bukszar J et al. Factor structure and external validity of the PANSS revisited. Schizophr Res 2006; 82: 213–223.
Kessler J, Folstein SE, Denzler P . Mini-Mental-Status-Test: German Version. Beltz: Weinheim, 1990.
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909.
Sawcer S, Jones HB, Judge D, Visser F, Compston A, Goodfellow PN et al. Empirical genomewide significance levels established by whole genome simulations. Genet Epidemiol 1997; 14: 223–229.
Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B et al. A high-resolution recombination map of the human genome. Nat Genet 2002; 31: 241–247.
International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851–861.
Voight BF, Kudaravalli S, Wen X, Pritchard JK . A map of recent positive selection in the human genome. PLoS Biol 2006; 4: e72.
Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen-White KR, Rosso A et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry 2002; 7: 851–859.
OMIM—Online Mendelian Inheritance in Man. OMIM 2008##http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim.
Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci 2005; 102: 15533–15538.
Jope RS, Roh MS . Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 2006; 7: 1421–1434.
Adli M, Hollinde DL, Stamm T, Wiethoff K, Tsahuridu M, Kirchheiner J et al. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry 2007; 62: 1295–1302.
Pickard BS, Malloy MP, Christoforou A, Thomson PA, Evans KL, Morris SW et al. Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol Psychiatry 2006; 11: 847–857.
Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73: 34–48.
Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger Jr JI et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73: 49–62.
Badner JA, Gershon ES . Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405–411.
Acknowledgements
Thanks to David Goldstein, Dongliang Ge, Kevin Shianna and Xiangyang Kong for producing and sharing well QC'd genotype data. Shaun Purcell, Silviu-Alin Bacanu and Lon Cardon provided critical thoughts and comments. John Strauss, Sagar Parikh, Jim Kennedy, Peter McGuffin and Ian Reid contributed to the bipolar case–control collection. We thank Lefkos Middleton and Allen Roses for their roles in assembling the case–control cohorts.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Rights and permissions
About this article
Cite this article
Francks, C., Tozzi, F., Farmer, A. et al. Population-based linkage analysis of schizophrenia and bipolar case–control cohorts identifies a potential susceptibility locus on 19q13. Mol Psychiatry 15, 319–325 (2010). https://doi.org/10.1038/mp.2008.100
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2008.100
Keywords
This article is cited by
-
A functional SNP rs895819 on pre-miR-27a is associated with bipolar disorder by targeting NCAM1
Communications Biology (2022)
-
DNA methylation of the KLK8 gene in depression symptomatology
Clinical Epigenetics (2021)
-
Epigenome-wide association study of depression symptomatology in elderly monozygotic twins
Translational Psychiatry (2019)
-
Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study
Molecular Psychiatry (2018)
-
Identity-by-descent mapping for diastolic blood pressure in unrelated Mexican Americans
BMC Proceedings (2016)